Patents by Inventor William W. van Osdol

William W. van Osdol has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210113541
    Abstract: A method and a non-rate controlled, monolithic, subsaturated patch for transdermally administering fentanyl and analogs thereof, for analgetic purposes, to a subject through skin over an extended period of time are disclosed.
    Type: Application
    Filed: December 21, 2020
    Publication date: April 22, 2021
    Inventors: Subramanian S. VENKATRAMAN, Shaoling LI, Robert M. GALE, Jane STEPIC, William W. VAN OSDOL
  • Publication number: 20200289488
    Abstract: A method and a non-rate controlled, monolithic, subsaturated patch for transdermally administering fentanyl and analogs thereof, for analgetic purposes, to a subject through skin over an extended period of time are disclosed.
    Type: Application
    Filed: May 28, 2020
    Publication date: September 17, 2020
    Inventors: Subramanian VENKATRAMAN, Shaoling LI, Robert M. GALE, Jane STEPIC, William W. VAN OSDOL
  • Publication number: 20200054619
    Abstract: A method and a non-rate controlled, monolithic, subsaturated patch for transdermally administering fentanyl and analogs thereof, for analgetic purposes, to a subject through skin over an extended period of time are disclosed.
    Type: Application
    Filed: October 24, 2019
    Publication date: February 20, 2020
    Inventors: Subramanian VENKATRAMAN, Shaoling LI, Robert M. GALE, Jane STEPIC, William W. VAN OSDOL
  • Publication number: 20200000791
    Abstract: Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.
    Type: Application
    Filed: May 7, 2019
    Publication date: January 2, 2020
    Inventors: Jan J. Scicinski, William W. van Osdol, Huey-Ching Su, Michael H. Arenberg, Jaymin Shah
  • Patent number: 10328068
    Abstract: Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: June 25, 2019
    Assignee: Durect Corporation
    Inventors: Jan J. Scicinski, William W. van Osdol, Huey-Ching Su, Michael H. Arenberg, Jaymin Shah
  • Publication number: 20190167655
    Abstract: A method and a non-rate controlled, monolithic, subsaturated patch for transdermally administering fentanyl and analogs thereof, for analgetic purposes, to a subject through skin over an extended period of time are disclosed.
    Type: Application
    Filed: February 8, 2019
    Publication date: June 6, 2019
    Inventors: Subramanian VENKATRAMAN, Shaoling Li, Robert M. Gale, Jane Stepic, William W. Van Osdol
  • Publication number: 20180214435
    Abstract: Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.
    Type: Application
    Filed: December 22, 2017
    Publication date: August 2, 2018
    Inventors: Jan J. Scicinski, William W. van Osdol, Huey-Ching Su, Michael H. Arenberg, Jaymin Shah
  • Publication number: 20180098979
    Abstract: A method and a non-rate controlled, monolithic, subsaturated patch for transdermally administering fentanyl and analogs thereof, for analgetic purposes, to a subject through skin over an extended period of time are disclosed.
    Type: Application
    Filed: December 8, 2017
    Publication date: April 12, 2018
    Inventors: SUBRAMANIAN S. VENKATRAMAN, SHAOLING LI, ROBERT M. GALE, JANE STEPIC, WILLIAM W. VAN OSDOL
  • Patent number: 9884056
    Abstract: Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.
    Type: Grant
    Filed: February 16, 2017
    Date of Patent: February 6, 2018
    Assignee: Durect Corporation
    Inventors: Jan J. Scicinski, William W. van Osdol, Huey-Ching Su, Michael H. Arenberg, Jaymin Shah
  • Publication number: 20170252330
    Abstract: Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.
    Type: Application
    Filed: February 16, 2017
    Publication date: September 7, 2017
    Inventors: Jan J. Scicinski, William W. van Osdol, Huey-Ching Su, Michael H. Arenberg, Jaymin Shah
  • Publication number: 20170196989
    Abstract: The present disclosure is directed to a method of making a composition by combining a vehicle, e.g., a single phase vehicle, and an insoluble component comprising a beneficial agent, and sterilizing the composition using ionizing radiation prior to use, wherein the beneficial agent is stable following exposure to a sterilizing dose of ionizing radiation. Related compositions and methods are provided.
    Type: Application
    Filed: December 19, 2016
    Publication date: July 13, 2017
    Applicant: Durect Corporation
    Inventors: Michael Sekar, Su Il Yum, Felix Theeuwes, William W. van Osdol
  • Publication number: 20170189547
    Abstract: The present disclosure provides a biodegradable drug delivery composition including a vehicle and an insoluble component comprising beneficial agent dispersed in the vehicle. Typically, the composition is not an emulsion, but has a low viscosity and further provides for minimized initial burst and sustained release of the beneficial agent over time. Also provided, are kits including the biodegradable drug delivery composition or components thereof, as well as methods of making and using the biodegradable drug delivery composition.
    Type: Application
    Filed: November 18, 2016
    Publication date: July 6, 2017
    Inventors: William W. van Osdol, Su Il Yum, Felix Theeuwes, Michael Sekar, John W. Gibson, Keith E. Branham, Huey-Ching Su
  • Patent number: 9616055
    Abstract: Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.
    Type: Grant
    Filed: July 2, 2015
    Date of Patent: April 11, 2017
    Assignee: Durect Corporation
    Inventors: Jan J. Scicinski, William W. van Osdol, Huey-Ching Su, Michael H. Arenberg, Jaymin Shah
  • Publication number: 20160331740
    Abstract: A method and a non-rate controlled, monolithic, subsaturated patch for transdermally administering fentanyl and analogs thereof, for analgetic purposes, to a subject through skin over an extended period of time are disclosed.
    Type: Application
    Filed: July 25, 2016
    Publication date: November 17, 2016
    Inventors: SUBRAMANIAN S. VENKATRAMAN, SHAOLING LI, ROBERT M. GALE, JANE STEPIC, WILLIAM W. VAN OSDOL
  • Publication number: 20160058746
    Abstract: Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.
    Type: Application
    Filed: July 2, 2015
    Publication date: March 3, 2016
    Inventors: Jan J. Scicinski, William W. van Osdol, Huey-Ching Su, Michael H. Arenberg, Jaymin Shah
  • Publication number: 20140271799
    Abstract: A method and a non-rate controlled, monolithic, subsaturated patch for transdermally administering fentanyl and analogs thereof, for analgetic purposes, to a subject through skin over an extended period of time are disclosed.
    Type: Application
    Filed: June 2, 2014
    Publication date: September 18, 2014
    Applicant: ALZA Corporation
    Inventors: SUBRAMANIAN S. VENKATRAMAN, SHAOLING LI, ROBERT M. GALE, JANE STEPIC, WILLIAM W. VAN OSDOL
  • Publication number: 20140193365
    Abstract: The present disclosure provides a biodegradable drug delivery composition including a vehicle and an insoluble component comprising beneficial agent dispersed in the vehicle. Typically, the composition is not an emulsion, but has a low viscosity and further provides for minimized initial burst and sustained release of the beneficial agent over time. Also provided, are kits including the biodegradable drug delivery composition or components thereof, as well as methods of making and using the biodegradable drug delivery composition.
    Type: Application
    Filed: December 10, 2013
    Publication date: July 10, 2014
    Applicant: Durect Corporation
    Inventors: William W. van Osdol, Su Il Yum, Felix Theeuwes, Michael Sekar, John W. Gibson, Keith E. Branham, Huey-Ching Su
  • Publication number: 20140030316
    Abstract: A method and a non-rate controlled, monolithic, subsaturated patch for transdermally administering fentanyl and analogs thereof, for analgetic purposes, to a subject through skin over an extended period of time are disclosed.
    Type: Application
    Filed: July 11, 2013
    Publication date: January 30, 2014
    Applicant: ALZA Corporation
    Inventors: Subramanian S. Venkatraman, Shaoling Li, Robert M. Gale, Jane Stepic, William W. Van Osdol
  • Publication number: 20140011842
    Abstract: Controlled release oral dosage forms suitable for administration of methylphenidate are provided. Abuse-resistant controlled release oral dosage forms suitable for administration of methylphenidate are also provided. Methods of treating ADD and ADHD using the oral dosage forms are also provided.
    Type: Application
    Filed: June 21, 2013
    Publication date: January 9, 2014
    Inventors: Jan J. Scicinski, William W. van Osdol, Huey-Ching Su, Michael H. Arenberg, Jaymin Shah
  • Publication number: 20120225033
    Abstract: The present disclosure provides a biodegradable drug delivery composition including a vehicle and an insoluble component comprising beneficial agent dispersed in the vehicle. Typically, the composition is not an emulsion, but has a low viscosity and further provides for minimized initial burst and sustained release of the beneficial agent over time. Also provided, are kits including the biodegradable drug delivery composition or components thereof, as well as methods of making and using the biodegradable drug delivery composition.
    Type: Application
    Filed: November 23, 2011
    Publication date: September 6, 2012
    Inventors: William W. van Osdol, Su il Yum, Felix Theeuwes, Michael Sekar, John Gibson, Keith Branham, Huey-Ching Su